CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models.
Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
无监督时间序列聚类识别出 CAR-T 细胞治疗后具有临床意义的不同血液学毒性模式。
免疫效应细胞相关血液毒性(ICAHT)是嵌合抗原受体(CAR)T细胞治疗后非复发死亡的重要原因。我们假设,与早期ICAHT(eICAHT)分级系统相比,无监督时间序列聚类能更好地识别早期血液毒性的典型模式。
我们对本中心691例患者CAR-T 细胞输注后第0至30天的纵向绝对中性粒细胞计数(ANC)数据,采用基于欧氏距离的无监督K均值时间序列聚类。训练集483例(70%),测试集208例(30%)。
训练集中,根据ANC恢复情况确定了最佳聚类方案,分为恢复极佳、良好、较差和极差4类。我们训练随机森林(RF)模型,纳入重要性最高的5个特征(第+3、+4、+5、+26和+27天ANC值)以预测类别,并在测试集中应用该模型。与eICAHT标准相比,RF预测的各聚类更紧凑、区分更好(Dunn指数:0.078比0.034;平均轮廓宽度:0.12比0.010)。此外,RF模型识别出恢复良好组患者的总生存期处于中间水平(风险比[HR] 1.70,95% CI 1.05–2.74;P=0.029;参照恢复极佳组);这一特征未能由2级eICAHT识别(HR 1.37,95% CI 0.80–2.35;P=0.25;参照0–1级)。
无监督时间序列聚类识别出CAR-T 细胞治疗后具有临床意义的不同血液毒性模式。我们训练并测试了一个仅用5个特征即可准确预测聚类归属的RF模型。预测可通过我们的在线网络应用程序生成。
Immune effector cell-associated hematotoxicity (ICAHT) is a major cause of nonrelapse mortality after chimeric antigen receptor (CAR) T-cell therapy. We hypothesized that unsupervised time-series clustering could better identify archetypal patterns of early hematotoxicity compared to the early ICAHT (eICAHT) grading system.
We applied unsupervised k-means time-series clustering based on Euclidean distances to longitudinal absolute neutrophil count (ANC) data from days +0 through +30 post-CAR T-cell infusion in 691 patients treated at our center (training set: n = 483, 70%; test set: n = 208, 30%).
Within our training set, we identified an optimal cluster solution based on four ANC recovery clusters, which were labeled as very good, good, poor, and very poor. We trained a random forest (RF) model including the top five most important features (day +3, +4, +5, +26, and +27 ANC values) to predict the cluster assignments. Within our test set, we applied the RF model to predict cluster assignments. Compared with the eICAHT criteria, the RF-predicted clusters were more compact and better separated (Dunn index: 0.078 v 0.034; average silhouette width: 0.12 v 0.010). In addition, the RF model identified patients in the good recovery cluster with intermediate overall survival (hazard ratio [HR], 1.70 [95% CI, 1.05 to 2.74]; P = .029; reference, very good), which was not captured by grade 2 eICAHT (HR, 1.37 [95% CI, 0.80 to 2.35]; P = .25; reference, grade 0-1).
Unsupervised time-series clustering identified distinct and clinically relevant patterns of hematotoxicity after CAR T-cell therapy. We trained and tested an RF model that accurately predicted cluster assignments using only five features. Predictions can be generated using our online web application.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。